Covalent aptamers: agents with promising therapeutic and diagnostic potential

Savannah Albright, Jessica Boette, Mary Cacace and Alexander Deiters

RSC Chem. Biol., 2026, 7, 9
DOI: 10.1039/D5CB00133A

Ultrasound-guided and activated nanodrugs for highly selective tumor therapy

Chuwen Luo, Ya Liu, Weidong Zhao, Jingchen Du, Wenye Tan, Yajun Xu, Zhaohui Tang and Xuesi Chen

Journal of Controlled Release, 2026, 393, 114755
DOI: 10.1016/j.jconrel.2026.114755

Electrophilic Compounds in the Human Diet and Their Role in the Induction of the Transcription Factor NRF2

Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, Celia Andrés Juan, Francisco J. Plou and Eduardo Pérez Lebeña

IJMS, 2024, 25, 3521
DOI: 10.3390/ijms25063521

Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors

Runchana Rungruangmaitree, Sakao Phoochaijaroen, Aunlika Chimprasit, Patchreenart Saparpakorn, Kusol Pootanakit and Duangrudee Tanramluk

Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-34305-6

Structure-property Relationships Reported for the New Drugs Approved in 2022

Kihang Choi

MRMC, 2024, 24, 330
DOI: 10.2174/1389557523666230519162803

Discovery of a 6-Aminobenzo[b]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic Activities

Patrik Oleksak, David Rysanek, Marketa Vancurova, Pavla Vasicova, Alexandra Urbancokova, Josef Novak, Dominika Maurencova, Pavel Kashmel, Jana Houserova, Romana Mikyskova, Ondrej Novotny, Milan Reinis, Pavel Juda, Miroslav Hons, Jirina Kroupova, David Sedlak, Tetyana Sulimenko, Pavel Draber, Marketa Chlubnova, Eugenie Nepovimova, Kamil Kuca, Miroslav Lisa, Rudolf Andrys, Tereza Kobrlova, Ondrej Soukup, Jiri Janousek, Lukas Prchal, Jiri Bartek, Kamil Musilek and Zdenek Hodny

ACS Pharmacol. Transl. Sci., 2024, 7, 2755
DOI: 10.1021/acsptsci.4c00190

Synthesis and Evaluation of Pseudoglucosinolates Releasing Isothiocyanates in the Presence of Azoreductases

Aishi Chakrabarti, Charity S. G. Ganskow, Mervic D. Kagho, Claire. C. Jimidar, Lorenz Wiese, Neslihan Beyazit, Ulrike Beutling, Margarita Seeger, Silvana Smits, Stella Nyström, Anne Farewell, Anett Schallmey, Mark Brönstrup and Philipp Klahn

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202500152

Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity

Mohammad Anwar Hossain, Abigail K. Mayo, Anirban Ghoshal, Sharon Taft-Benz, Elizabeth Anderson, Noah L. Morales, Katia D. Pressey, Ava Vargason, Kim L. R. Brouwer, Nathaniel J. Moorman, Mark T. Heise and Timothy M. Willson

J. Med. Chem., 2025, 68, 10473
DOI: 10.1021/acs.jmedchem.5c00825

Rat Sarcoma (RAS)-Protein-Targeting Synthetic Cell-Penetrating Peptide as an Anticancer Biomaterial

Gookjin Yoon, Jinsook Suh, Beom Soo Jo, Dong Woo Lee, Deogil Kim, Moonsil Choi, Eui Kyun Jeong, Hoo Cheol Lee, Hye Min Shin, Yu-Bin Kim, Sanghui Seok, Yoon Shin Park, Chong Pyung Chung, Jue-Yeon Lee and Yoon Jeong Park

Biomater Res, 2025, 29
DOI: 10.34133/bmr.0175

An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity

DongHoon Yu, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen, Friedrich Hahn, Benedikt B. Kaufer, Frank Neipel, Jan Eickhoff, Bert Klebl, Kiyean Nam and Manfred Marschall

Pharmaceutics, 2024, 16, 158
DOI: 10.3390/pharmaceutics16020158

Benzothiazole sulfones as a tool for peptide modification and cleavage

Phoebe R. Rubio, Gavin A. Clausen, Zachary D. Ruighaver, Abigail F. Dalton, John P. Blobe, Amanda L. Moore and Christopher R. Shugrue

Bioorganic & Medicinal Chemistry, 2026, 133, 118500
DOI: 10.1016/j.bmc.2025.118500

Two-Step Covalent Docking with Attracting Cavities

Mathilde Goullieux, Vincent Zoete and Ute F. Röhrig

J. Chem. Inf. Model., 2023, 63, 7847
DOI: 10.1021/acs.jcim.3c01055

Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors

Junming He, Henry Illingworth, Sven Ullrich, Pritha Ghosh, Jennifer Ton, Colin J. Jackson and Christoph Nitsche

Bioorganic & Medicinal Chemistry Letters, 2025, 122, 130176
DOI: 10.1016/j.bmcl.2025.130176

One-Shot Rational Design of Covalent Drugs with CovalentLab

Xi Xue, Xiangying Liu, Xue Liu, Hanyu Sun, Shize Li, Kai Chen, Hanmiao Xu, Liangning Li, Chengxia Mao, Jingjie Yan, Peilan Yang, Baolian Wang, Tingjun Hou, Tingting Du and Xiaojian Wang

JACS Au, 2025, 5, 5676
DOI: 10.1021/jacsau.5c01161

Covalent targeting GAPDH by Pudilan formula and baicalein suppresses macrophage Warburg effect to alleviate acute lung injury

Mengyao Jiang, Yang Yang, Ying Zhang, Panpan Zhang, Qianyu Zhang, Tong Yang, Guoxin Zhang, Jie Zhou, Zheng Chu, Shuyu Li, Yaxu Wang, Junzhe Zhang, Shengnan Shen, Ping Song, Jigang Wang and Huan Tang

Phytomedicine, 2026, 151, 157727
DOI: 10.1016/j.phymed.2025.157727

Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis

Danni Rao, Tao Yang, Huixu Feng, Qi An, Shaofeng Zhang, Jinghua Yu, Xuelian Ren, Xingxing Diao, He Huang, Wei Tang and Shilin Xu

J. Med. Chem., 2023, 66, 12018
DOI: 10.1021/acs.jmedchem.3c00606

Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis

Yibing Wang, Jianan Zheng, Yun Long, Wenyi Wu and Yutong Zhu

Biochemical Pharmacology, 2024, 220, 115989
DOI: 10.1016/j.bcp.2023.115989

In‐Silico Exploration of the StreptomeDB Database for Potential Irreversible DprE1 Inhibitors toward Antitubercular Treatment

Doaa G. M. Mahmoud, Gamal A. H. Mekhemer, Mohamed‐Elamir F. Hegazy, Jabir H. Al‐Fahemi and Mahmoud A. A. Ibrahim

ChemistryOpen, 2025, 14
DOI: 10.1002/open.202500237

Sulfur-and selenium-targeting warheads: reaction-based design of electrophilic warheads for selective inhibition of enzyme

Neha Jain and Michio Iwaoka

Front. Chem., 2026, 14
DOI: 10.3389/fchem.2026.1768658

Beyond Inhibition: Emerging Small-Molecule Modalities in Oncology (Molecular Glues, Covalents, and Radiotheranostics)

Salvation Ifechukwude Atalor, Aliaa Mohammed Mahmoud Soliman, Oluwatobiloba Kehinde Adedokun, Modinat Aina, Abayomi, Cecilia Chika Unegbu, Okoroafor Dorcas Okayo, Victor Jonathan, Kingsley Ugonna Ugoagwu and Aliyu Olanrewaju Olaniyi

Australian Journal of Biomedical Research, 2025, 1
DOI: 10.63946/aubiomed/17089

Comprehensive exploration of isocitrate dehydrogenase (IDH) mutations: Tumorigenesis, drug discovery, and covalent inhibitor advances

Conghao Gai, Hairong Zeng, Haoming Xu, Xiaoyun Chai, Yan Zou, Chunlin Zhuang, Guangbo Ge and Qingjie Zhao

European Journal of Medicinal Chemistry, 2025, 282, 117041
DOI: 10.1016/j.ejmech.2024.117041

Mechanistic Insights of a p53-Targeting Small Molecule

Ricardo J. F. Ferreira, Valentina Barcherini, Catarina Roma-Rodrigues, Miriama Sikorová, Lucília Saraiva, Ana P. Leandro, Pedro V. Baptista, Alexandra R. Fernandes, Alexandra M. M. Antunes and Maria M. M. Santos

ACS Pharmacol. Transl. Sci., 2025, 8, 1726
DOI: 10.1021/acsptsci.5c00110

Review of peptidomimetic vinyl sulfones targeting cysteine proteases and proteasomes

Reza Ahmadi and Saeed Emami

Bioorganic Chemistry, 2026, 168, 109323
DOI: 10.1016/j.bioorg.2025.109323